日期 影响因子
日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:
–

The Charité protocol for surveillance, treatment and after-care management in women with Lynch syndrome

夏里特医院针对林奇综合征女性患者的监测、治疗和后续护理管理方案

期刊:Archives of Gynecology and Obstetrics
影响因子:2.5
doi:10.1007/s00404-025-08112-5
Chinczewski, Lukas; Chekerov, Radoslav; Daum, Severin; Ott, Claus-Eric; Sehouli, Jalid
发表日期：2025
文献求助 收藏

Pre-Operative Malnutrition in Patients with Ovarian Cancer: What Are the Clinical Implications? Results of a Prospective Study

卵巢癌患者术前营养不良：其临床意义是什么？一项前瞻性研究的结果

期刊:Cancers
影响因子:4.4
doi:10.3390/cancers16030622
Nasser, Sara; Bilir, Esra; Derin, Xezal; Richter, Rolf; Grabowski, Jacek P; Ali, Paulina; Kulbe, Hagen; Chekerov, Radoslav; Braicu, Elena; Sehouli, Jalid
卵巢癌
肿瘤
肿瘤免疫
发表日期：2024
文献求助 收藏

Ovarian cancer management in an ESGO ovarian cancer center of excellence: a systematic case study of the interprofessional and interdisciplinary interaction

ESGO卵巢癌卓越中心的卵巢癌管理：跨专业和跨学科互动的系统案例研究

期刊:Archives of Gynecology and Obstetrics
影响因子:2.5
doi:10.1007/s00404-023-07368-z
Krankenberg, David J; Muallem, Mustafa Zelal; Pietzner, Klaus; Chekerov, Radoslav; Armbrust, Robert; Beteta, Carmen; Schöning, Wenzel; Lee, Marlene; Klews, Julia; Sehouli, Jalid
肿瘤
肿瘤免疫
卵巢癌
发表日期：2024
文献求助 收藏

INOVATYON/ ENGOT-ov5 study: Randomized phase III international study comparing trabectedin/pegylated liposomal doxorubicin (PLD) followed by platinum at progression vs carboplatin/PLD in patients with recurrent ovarian cancer progressing within 6-12 months after last platinum line

INOVATYON/ENGOT-ov5 研究：一项随机 III 期国际研究，比较曲贝替定/聚乙二醇化脂质体阿霉素 (PLD) 序贯铂类化疗与卡铂/PLD 方案治疗复发性卵巢癌（末次铂类化疗后 6-12 个月内进展）患者的疗效。

期刊:British Journal of Cancer
影响因子:6.8
doi:10.1038/s41416-022-02108-7
Colombo, N; Gadducci, A; Sehouli, J; Rulli, E; Mäenpää, J; Sessa, C; Montes, A; Ottevanger, N B; Berger, R; Vergote, I; D'Incalci, M; Churruca Galaz, C; Chekerov, R; Nyvang, G B; Riniker, S; Herbertson, R; Fossati, R; Barretina-Ginesta, M P; Deryal, M; Mirza, M R; Biagioli, E; Iglesias, M; Funari, G; Romeo, M; Tasca, G; Pardo, B; Tognon, G; Rubio-Pérez, M J; DeCensi, A; De Giorgi, U; Zola, P; Benedetti Panici, P; Aglietta, M; Arcangeli, V; Zamagni, C; Bologna, A; Westermann, A; Heinzelmann-Schwarz, V; Tsibulak, I; Wimberger, P; Poveda, A
肿瘤
ENG
肿瘤免疫
卵巢癌
发表日期：2023
文献求助 收藏

Pazopanib with Topotecan weekly for patients with platinum-resistant or intermediate-sensitive recurrent ovarian cancer: results of a multicentre, open label phase I/II study (TOPAZ)

帕唑帕尼联合拓扑替康每周治疗铂耐药或中度敏感复发性卵巢癌患者：一项多中心、开放标签 I/II 期研究 (TOPAZ) 的结果

期刊:Journal of Cancer Research and Clinical Oncology
影响因子:2.8
doi:10.1007/s00432-023-04647-9
Chekerov, Radoslav; Arndt, Tjadina; Pietzner, Klaus; Canzler, Ulrich; Wimberger, Pauline; Strauß, Hans-Georg; Mahner, Sven; Woelber, Linn; de Gregorio, Nikolaus; Stocker, Gertraud; von Abel, Ekkehard; Neunhoeffer, Tanja; Belau, Antje Kristina; Mustea, Alexander; Yalinkaya, Isil; Braicu, Elena Ioana; Richter, Rolf; Sehouli, Jalid
肿瘤
肿瘤免疫
卵巢癌
发表日期：2023
文献求助 收藏

HE4 as a serum biomarker for the diagnosis of pelvic masses: a prospective, multicenter study in 965 patients

HE4作为血清生物标志物在盆腔肿块诊断中的应用：一项纳入965例患者的前瞻性多中心研究

期刊:BMC Cancer
影响因子:3.4
doi:10.1186/s12885-022-09887-5
Braicu, Elena Ioana; Krause, Catherine Linn; Torsten, Uwe; Mecke, Herbert; Richter, Rolf; Hellmeyer, Lars; Lanowska, Malgorzata; Müller, Bodo; Koch, Elisa; Boenneß-Zaloum, Janine; Ames, Kerstin; Chekerov, Radoslav; Hasenbein, Kati; Zimmermann, Mathias; Mangler, Mandy; Chen, Frank; Tauber, Rudolf; Sehouli, Jalid
发表日期：2022
文献求助 收藏

Can a morphological description of the peritoneal carcinomatosis in advanced ovarian cancer add prognostic information? Analysis of 1686 patients of the tumor bank ovarian cancer

晚期卵巢癌腹膜癌的形态学描述能否提供预后信息？对肿瘤库中1686例卵巢癌患者的分析

期刊:Frontiers in Oncology
影响因子:3.3
doi:10.3389/fonc.2022.1014073
Nasser, Sara; Babayeva, Aygun; Braicu, Ioana; Richter, Rolf; Bilir, Esra; Chekerov, Radoslav; Muallem, Mustafa-Zelal; Pietzner, Klaus; Inci, Melissa-Guelhan; Sehouli, Jalid
肿瘤
肿瘤免疫
卵巢癌
发表日期：2022
文献求助 收藏

Surgery due to mechanical bowel obstruction in relapsed ovarian cancer: clinical and surgical results of a bicentric analysis of 87 patients

复发性卵巢癌并发机械性肠梗阻的手术治疗：一项纳入87例患者的双中心分析的临床和手术结果

期刊:Archives of Gynecology and Obstetrics
影响因子:2.5
doi:10.1007/s00404-021-06237-x
Armbrust, R; Chekerov, R; Sander, S; Biebl, M; Chopra, S; Krell, Jonathan; Rinne, Natasha; Nixon, Katherine; Fotopoulou, C; Sehouli, J
肿瘤
肠梗阻
肿瘤免疫
卵巢癌
发表日期：2022
文献求助 收藏

Correction to: Surgery due to mechanical bowel obstruction in relapsed ovarian cancer: clinical and surgical results of a bicentric analysis of 87 patients

更正：复发性卵巢癌机械性肠梗阻手术：87例患者的双中心分析的临床和手术结果

期刊:Archives of Gynecology and Obstetrics
影响因子:2.5
doi:10.1007/s00404-021-06322-1
Armbrust, R; Chekerov, R; Sander, S; Biebl, M; Chopra, S; Krell, Jonathan; Rinne, Natasha; Nixon, Katherine; Fotopoulou, C; Sehouli, J
肿瘤
肠梗阻
肿瘤免疫
卵巢癌
发表日期：2022
文献求助 收藏

Cell-Free-DNA-Based Copy Number Index Score in Epithelial Ovarian Cancer-Impact for Diagnosis and Treatment Monitoring

基于游离DNA的拷贝数指数评分在卵巢上皮癌诊断和治疗监测中的作用

期刊:Cancers
影响因子:4.4
doi:10.3390/cancers14010168
Braicu, Elena Ioana; du Bois, Andreas; Sehouli, Jalid; Beck, Julia; Prader, Sonia; Kulbe, Hagen; Eiben, Bernd; Harter, Philipp; Traut, Alexander; Pietzner, Klaus; Glaubitz, Ralf; Ataseven, Beyhan; Chekerov, Radoslav; Keck, Christoph; Winkler, Thomas; Heikaus, Sebastian; Gellendin, Peggy; Schütz, Ekkehard; Heitz, Florian
肿瘤
肿瘤免疫
发表日期：2021
文献求助 收藏